drugset / Trial / NCT02967887
Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC
NaSingle-groupOpen-labelTreatment
Summary
This study is to assess the efficacy and the safety of hepatic arterial infusion of cisplatin and 5-fluorouracil (HAIC) in advanced HCC patients stratified by biomarker expression predicting therapeutic response.
Timeline
- Start
- 2016-11
- Primary completion
- 2018-10
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | Other |
| Subject | fluorouracil | Small molecule | 500 mg/m2 | Other |